May 1 (Reuters) - Ophthotech Corp:
* OPHTHOTECH COMPLETES PATIENT RECRUITMENT IN THE PHASE 2A CLINICAL TRIAL OF ZIMURA® IN COMBINATION WITH ANTI-VEGF THERAPY IN WET AGE-RELATED MACULAR DEGENERATION
* OPHTHOTECH CORP - INITIAL TOP-LINE DATA EXPECTED BY END OF 2018
* OPHTHOTECH CORP - WILL EVALUATE DATA AT MONTH 6 Source text for Eikon: Further company coverage: